Figure 10.
Blockade of terminal complement activation, adapted from [149]. Eculizumab binds to C5 and prevents the formation of the membrane attack complex by reducing cleavage of C5 to C5a and C5b.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.